References
- Feldman HA, Longcope C, Derby CA, et al Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2002;87:589–598
- Heller CG, Myers GB. The male climacteric, its symptomatology, diagnosis and treatment. JAMA 1944;126:472–477
- Liu PY, Swerdloff RS, Veldhuis JD. The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations. J Clin Endocrinol Metab 2004;89:4789–4796
- Gould DC, Petty R. For and against: The male menopause – does it exist? BMJ 2000;320:858–860
- Jacobs HS. For and against: The male menopause – does it exist? BMJ 2000;320:860–861
- Spetz AC, Palmefors L, Skobe RS, et al Testosterone correlated to symptoms of partial androgen deficiency in aging men (PADAM) in an elderly Swedish population. Menopause 2007;14:999–1005
- Huhtaniemi I, Mäkinen JI, Perheentupa A, Raitakari OT. Late-onset hypogonadism in men. Experience from the Turku Male Ageing Study (TuMAS). Hormones (Athens) 2008;7:36–45
- McKinlay JB, Travison TG, Araujo AB, Kupelian V. Male menopause: time for a decent burial? Menopause 2007;14:973–975
- Wu FC, Tajar A, Beynon JM, et al Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010; Jun 16. Epub ahead of print
- Wang C, Nieschlag E, Swerdloff RS, et al ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 2009;12:5–12